Navigation Links
Ambit Biosciences to Present at Two Upcoming Investor Conferences
Date:2/9/2012

SAN DIEGO, Feb. 9, 2012 /PRNewswire/ -- Ambit Biosciences today announced that Michael A. Martino, Ambit's president and chief executive officer, will provide an overview of the company and an update about its clinical development programs, including quizartinib, at two upcoming investor conferences at the Waldorf Astoria in New York City.

  • 14th Annual BIO CEO & Investor Conference
    • Presentation: 1:30 p.m. EST on Monday, February 13, 2012
  • Leerink Swann 2012 Global Healthcare Conference
    • Presentation: 8 a.m. EST on Thursday, February 16, 2012

About Quizartinib
Quizartinib, formerly known as AC220, is being developed in collaboration between Ambit Biosciences and Astellas Pharma Inc. and is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor.  Quizartinib is currently under evaluation in a Phase 2 clinical trial as monotherapy treatment for adult and elderly patients with relapsed/refractory AML that have an internal tandem duplication (ITD) mutation in the FLT3 gene.

About Ambit Biosciences
Ambit Biosciences is a privately held biopharmaceutical company engaged in the development of a robust pipeline of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease and other indications. Ambit's lead compound, quizartinib (AC220), is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor, and is currently under clinical investigation in patients with relapsed or refractory AML. Ambit is developing quizartinib in collaboration with Astellas Pharma Inc. as part of a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications. In addition to quizartinib, Ambit's clinical pipe
'/>"/>

SOURCE Ambit Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia
2. Ambit Biosciences Announces Transition in Company Leadership
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
5. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
6. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
7. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
8. Milestone Biosciences, LLC Further Strengthens Executive Management Team
9. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
10. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
11. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... September 2014 Die zweite jährliche ... 12. bis 18. Oktober stattfinden. Die IPAW ist ... Association (PPTA) und ihrer Mitgliedsunternehmen ... globale Bewusstsein für die Gewinnung von Quellplasma zu ... Retten und Verbessern von Leben zu würdigen ...
(Date:9/15/2014)... 2014 La segunda anual International Plasma Awareness ... 18 de octubre. Como iniciativa conjunta de la Plasma ... miembro s, la IPAW se ha diseñado para: ... colección de fuentes de plasma , Reconocimiento de las ... las vidas , Aumento del conocimiento sobre salvar vidas ...
(Date:9/15/2014)... GA (PRWEB) September 15, 2014 ... http://www.hydrodynamics.com ) announced today that it will be ... Estates, CA ( http://www.proteaf.com ) for implementing its ... high value continuous processing. Continuous flow chemistry ... the chemical, pharmaceutical and petrochemical markets for decades. ...
(Date:9/14/2014)... in a wide variety of ways, including by modifying ... take on another form and perform no or even ... can cause serious diseases such as Alzheimer,s, Parkinson,s or ... tendency to "infect" other molecules of the same type ... These amyloids can damage cells and tissues and make ...
Breaking Biology Technology:International Plasma Awareness Week feiert Spender und rückt seltene Krankheiten in den Mittelpunkt 2International Plasma Awareness Week feiert Spender und rückt seltene Krankheiten in den Mittelpunkt 3La International Plasma Awareness Week será una celebración para los donantes 2La International Plasma Awareness Week será una celebración para los donantes 3Hydro Dynamics Partners with the Continuous Flow Chemistry Experts of Proteaf Technologies 2Measuring modified protein structures 2Measuring modified protein structures 3
... November 20 SPO Medical Inc. (OTC:,SPOM - News), ... in portable monitoring devices, announced its results,for the nine-month ... Despite the continued deterioration in the ... US$2,421,000; declines in sales,were mainly due to the lower ...
... International plc,(LSE: CEL.L), the global leader in rapid ... of RapiScreen(TM) Beverage, a new assay,for use on ... microbial,screening instrument for dairy products. This new rapid ... efficiently and rapidly screen Ultra,Heat Treated (UHT) and ...
... - GeneNews Limited (TSX: GEN), a company ... the early detection of diseases and personalized ... Laboratories, leading providers of laboratory services, information ... specimen collection services for ColonSentry(TM), the world,s ...
Cached Biology Technology:SPO Medical Reports Nine Month Period Ending September 2008 2SPO Medical Reports Nine Month Period Ending September 2008 3Celsis Launches RapiScreen(TM) Beverage Microbial Screening System 2GeneNews rolls out ColonSentry(TM) test in additional Toronto area labs 2GeneNews rolls out ColonSentry(TM) test in additional Toronto area labs 3GeneNews rolls out ColonSentry(TM) test in additional Toronto area labs 4
(Date:9/15/2014)... diseases requires that the proteins in our cells cooperate ... secret how tens of thousands of different proteins find ... up the human body, brain and nervous system. A ... Chemistry has busted down the door and provided a ... dance floor. , Professor emeritus Jens Jrgen Led of ...
(Date:9/15/2014)... life it,s not what comes to mind when you ... of Doncaster,s 310-million-year-old past, including a fossilised shark egg case, ... of the fossilised plants and creatures may even be new ... horseshoe crabs and some previously unrecorded seed pods are amongst ... formed within the coal and shale deposits in what is ...
(Date:9/15/2014)... , , , , , ... , , , , ... disorders, each with its own set of symptoms. The finding could be a first... , , ... , , , , , ... , , , , , , , New ...
Breaking Biology News(10 mins):Protein courtship revealed through chemist's lens 2Protein courtship revealed through chemist's lens 3'Jaws' lived in Doncaster 2Schizophrenia not a single disease but multiple genetically distinct disorders 2Schizophrenia not a single disease but multiple genetically distinct disorders 3Schizophrenia not a single disease but multiple genetically distinct disorders 4Schizophrenia not a single disease but multiple genetically distinct disorders 5
... COLUMBIA, Mo. Pairing a new approach to prepare ... to genotype a cow, an MU animal scientist, along ... accurate and widespread "family tree" for cows and other ... This genetic information could allow scientists to understand the ...
... Old Orchard Beach, Maine, a doctoral student in ... fellowship from the Environmental Protection Agency,s (EPA) National ... the reproductive success of American toads. Bergeron,s ... Results (STAR) program, ( http://www.epa.gov/ncer/fellow/ ), will support ...
... Tropical Research Institute in Panama has dramatically improved the ... spread of chytridiomycosisone of the deadliest frog diseases on ... dendrobatidis , this disease is probably responsible for the ... During the past decade, the epidemic swept from the ...
Cached Biology News:MU research team establishes family tree for cattle, other ruminants 2EPA fellow studies effect of mercury in toads 2Catching a killer one spore at a time 2
Human Glypican 2 Biotinylated Affinity Purified PAb...
Human Contactin-2/TAG1 Affinity Purified Polyclonal Ab...
Tachykinin (H-2)...
Human BMP 2 Construction Kit provides antigen affinity purified polyclonal capture and tracer antibodies, and antigen standard for development of approximately ten microplate assays....
Biology Products: